|
GRINL1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.915700E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.550700E-04 |
| Normal-vs-Stage2 |
5.063000E-01 |
| Normal-vs-Stage3 |
1.924380E-01 |
| Normal-vs-Stage4 |
8.918800E-01 |
| Stage1-vs-Stage2 |
2.114800E-01 |
| Stage1-vs-Stage3 |
2.677000E-01 |
| Stage1-vs-Stage4 |
2.031600E-01 |
| Stage2-vs-Stage3 |
7.786800E-01 |
| Stage2-vs-Stage4 |
7.867400E-01 |
| Stage3-vs-Stage4 |
5.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.240960E-03 |
| Normal-vs-AfricanAmerican |
1.023020E-01 |
| Normal-vs-Asian |
4.576500E-02 |
| Caucasian-vs-AfricanAmerican |
3.512200E-01 |
| Caucasian-vs-Asian |
7.730800E-01 |
| AfricanAmerican-vs-Asian |
5.629600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.812400E-04 |
| Normal-vs-Female |
2.068000E-01 |
| Male-vs-Female |
5.690000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.038200E-02 |
| Normal-vs-Extreme_Weight |
7.397700E-04 |
| Normal-vs-Obese |
1.392380E-01 |
| Normal-vs-Extreme_Obese |
1.033700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.105600E-01 |
| Normal_Weight-vs-Obese |
5.983800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.666400E-01 |
| Extreme_Weight-vs-Obese |
1.394780E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.897200E-01 |
| Obese-vs-Extreme_Obese |
3.410200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.236000E-02 |
| Normal-vs-Age(41-60Yrs) |
7.725900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.609700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.637270E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.334600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.686200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.179600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.416400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.435990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.756000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.496500E-03 |
| Normal-VS-Type2 PRCC |
3.622000E-03 |
| Normal-VS-KIRP CIMP |
2.539400E-01 |
| Normal-VS-Unclassified PRCC |
3.110200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.974400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.682000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.899400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.085800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.649200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.402000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.045140E-04 |
| Normal-vs-N1 |
3.799400E-01 |
| Normal-vs-N2 |
3.122600E-01 |
| N0-vs-N1 |
1.001020E-01 |
| N0-vs-N2 |
4.654400E-01 |
| N1-vs-N2 |
8.234400E-01 |
|
|
